Onconetix and Ocuvex terminate merger agreement mutually

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. MSFT
3. SPY
4. CSCO
5. KTOS
6. PLTR
7. NVDA
8. META
9. HOOD
10. AMZN

Go back to Onconetix and Ocuvex terminate merger agreement mutually

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

September 26, 2025 8:15 AM EDT

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company focused on innovative solutions for men's health and oncology, and Ocuvex Therapeutics, Inc., a leader in ophthalmic innovation, today announced the mutual termination of their previously announced definitive merger agreement, dated July 16, 2025.

After careful consideration and constructive dialogue, both companies have jointly determined that pursuing independent paths is in the best interests of their respective stakeholders. This decision reflects the strong commitment of both Onconetix and Ocuvex to advancing their respective missions and delivering value to... More